Analytical testing, QC

Wave of acquisitions hits pharma industry this week

15-Jul-2021 By Jenni Spinner

The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.

Cryo-EM advancements lead to ‘resolution revolution’: Thermo Fisher

22-Jun-2021 By Jenni Spinner

An academic researcher and and company expert discuss on how evolving cryogenic electron microscopy has led to high resolutions and accelerated results.

Azzur opens new on-demand cleanroom facility in California

03-Jun-2021 By Jenni Spinner

The company’s Azzur Cleanrooms on Demand division has established another facility in Vista, a city in the San Diego Area, for life-sciences operations.

Lonza leader outlines small-molecule trends for 2021 and beyond

06-May-2021 By Jenni Spinner

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

Latest FDA COVID-19-related advice and actions

04-May-2021 By Jenni Spinner

The US agency continues to keep a watchful eye over the nation’s pandemic response, issuing advice to professionals and taking action where appropriate.

PRA expands COVID-19 pharmacovigilance resources

04-May-2021 By Jenni Spinner

The CRO is offering an expanded range of post-authorization solutions designed to help developers with treatments and vaccines in their product pipeline

Study examines solution to gauge adverse drug event risk

26-Apr-2021 By Jenni Spinner

Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.

Cancer detection tech uses AI, whole-genome sequencing

22-Apr-2021 By Jenni Spinner

An advanced cancer detection platform from C2i Genomics (reportedly capable of spotting miniscule traces of the disease) recently landed $100m in funding.

COVID-19 highlights need for digital lab connectivity: Waters

22-Apr-2021 By Jenni Spinner

A leader from the laboratory solutions provider talks about how the virus has created challenges for researchers, and how those obstacles might be cleared.

Immunomics firm reels in $14m to advance drug discovery

20-Apr-2021 By Jenni Spinner

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

Novartis, Artios cancer discovery deal worth up to $1.3bn

12-Apr-2021 By Jenni Spinner

The collaboration centers on development of precision cancer treatments, through discovery and validation of next-generation DNA damage response targets.

IQVIA completes acquisition of Q2 Diagnostics

05-Apr-2021 By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

Vocal biomarkers enable unique diagnosis, monitoring capabilities

02-Mar-2021 By Jenni Spinner

A leader from Vocalis Health explains how health data can be culled from patient voice recordings to screen and monitor COVID-19 and other conditions.

On-demand capabilities help drug developers in a pinch

18-Feb-2021 By Jenni Spinner

With demand for fast-tracking therapies, vaccines and other products increasing, companies like Azzur Group offer the ability to add capabilities quickly.